Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States-Reference-Cited by-同舟云学术

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States

Published:2017-04-01 Issue:2 Volume:35 Page:79-83
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Stepanova Maria¹²,Clement Stephen³,Wong Robert⁴,Saab Sammy⁵,Ahmed Aijaz⁶⁷,Younossi Zobair M.¹²⁸

Affiliation:

1. Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA

2. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA

3. Section of Endocrinology, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA

4. Division of Gastroenterology and Hepatology, Alameda Health System—Highland Hospital Campus, Oakland, CA

5. Departments of Medicine and Surgery, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA

6. Department of Surgery, Stanford University School of Medicine, Stanford, CA

7. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA

8. Department of Medicine, Inova Fairfax Hospital, Falls Church, VA

Abstract

IN BRIEF Chronic liver disease (CLD) and type 2 diabetes have both been linked to increased morbidity and mortality. In this study, the impact of CLD and diabetes on all-cause mortality was quantified at the population level using U.S. population data. Both type 2 diabetes and CLD were found to be independently associated with increased mortality (age-adjusted hazard ratio [aHR] 1.98 and 1.37 for diabetes and CLD, respectively), and having both diabetes and CLD substantially increased the risk of mortality (aHR 2.41).

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/35/2/79/500556/79.pdf

Reference20 articles.

1. Centers for Disease Control and Prevention . Chronic diseases: the leading causes of death and disability in the United States [Internet]. Available from http://www.cdc.gov/chronicdisease/overview. Accessed 20 June 2016

2. Summary health statistics for US adults: National Health Interview Survey, 2010;Schiller;Vital Health Stat 10,2012

3. Centers for Disease Control and Prevention/National Center for Health Statistics . Health Interview Survey, 1997–2014: sample adult core component. Early release of selected estimates based on data from the National Health Interview Survey, 2014: diagnosed diabetes [Internet]. Available from http://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201506_14.pdf. Accessed 20 June 2016

4. Centers for Disease Control and Prevention/National Center for Health Statistics . Health Interview Survey, 1997–2014: sample adult core component. Early release of selected estimates based on data from the National Health Interview Survey, 2014: diagnosed obesity [Internet]. Available from http://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201506_06.pdf. Accessed 20 June 2016

5. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010;Flegal;JAMA,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Original Article: Liver disease, heart failure, and 13-year mortality among Mexican American older adults: Nativity differences;Annals of Epidemiology;2023-12

2. The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study (NASH‐CO study);Liver International;2023-07-14

3. Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States;Digestive and Liver Disease;2023-01

4. Albuminuria as a predictor of mortality in type II diabetic patients after living-donor liver transplantation;Annals of Medicine;2022-09-26

5. Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz;Die Diabetologie;2022-04-27